| 1. |
Welsby IJ, Newman MF, Phillips-Bute B, et al. Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery. Anesthesiology, 2005, 102(2): 308-314.
|
| 2. |
Kimmel SE, Sekeres M, Berlin JA, et al. Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass. Anesth Analg, 2002, 94(6): 1402-1408.
|
| 3. |
Raikar GV, Hisamochi K, Raikar BL, et al. Nitric oxide inhibition attenuates systemic hypotension produced by protamine. J Thorac Cardiovasc Surg, 1996, 111(6): 1240-1246.
|
| 4. |
Kalathottukaren MT, Abraham L, Kapopara PR, et al. Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA. Blood, 2017, 129(10): 1368-1379.
|
| 5. |
Sommers CD, Ye H, Liu J, et al. Heparin and homogeneous model heparin oligosaccharides form distinct complexes with protamine: Light scattering and zeta potential analysis. J Pharm Biomed Anal, 2017, 140: 113-121.
|
| 6. |
方強, 石應康, 張爾永, 等. 心內直視術中魚精蛋白毒副反應的危險因素分析. 中國胸心血管外科臨床雜志, 2003, 10(3): 177-180.
|
| 7. |
Gueugniaud PY, David JS, Chanzy E, et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med, 2008, 359(1): 21-30.
|
| 8. |
Fulton LV, Aitken J, Avery J, et al. Comparative resuscitative methods for venlafaxine toxicity in a swine model. Mil Med, 2016, 181(4): 383-388.
|
| 9. |
陳永福, 羅業春, 覃祖光. 體外循環術后不同途徑輸注魚精蛋白對血流動力學的影響. 中國現代藥物應用, 2015, 9(5): 103-104.
|
| 10. |
楊彥博, 任旭東, 張巧燕, 等. 不同途徑中和肝素對先天性心臟病合并肺動脈高壓術后肺循環的影響. 重慶醫學, 2013, 42(34): 4152-4154.
|
| 11. |
張為民, 申偉林, 張帥, 等. 小量預注法預防魚精蛋白毒性反應的臨床觀察. 中國社區醫師, 2013, 15(20): 18-19.
|
| 12. |
陳青云, 華東, 鄭和平. 氯化鈣預防魚精蛋白不良反應臨床觀察. 罕少疾病雜志, 2013, 20(3): 37-41.
|